An Investigational Drug Study to Treat Respiratory Symptoms Associated With Respiratory Syncytial Virus (RSV) Bronchiolitis (0476-272)
PHASE3CompletedINTERVENTIONAL
Enrollment
1,125
Participants
Timeline
Start Date
August 31, 2003
Primary Completion Date
June 30, 2006
Study Completion Date
October 31, 2006
Conditions
Bronchiolitis
Interventions
DRUG
montelukast sodium
Duration of Treatment: 6 months
DRUG
Comparator: placebo
Duration of Treatment: 6 months
All Listed Sponsors
lead
Organon and Co
INDUSTRY
NCT00076973 - An Investigational Drug Study to Treat Respiratory Symptoms Associated With Respiratory Syncytial Virus (RSV) Bronchiolitis (0476-272) | Biotech Hunter | Biotech Hunter